Latest Breaking News On - Chairperson or co - Page 1 : vimarsana.com

VNET : NOTICE OF EXTRAORDINARY GENERAL MEETING - Form 6-K -December 08, 2023 at 06:08 am EST

NOTICE OF EXTRAORDINARY GENERAL MEETING To be held on January 9, 2024 NOTICE IS HEREBY GIVEN that an extraordinary general meeting of VNET Group, Inc. will be.

Grand caymanCayman islandsNew yorkUnited statesNew york stock exchangeSheng chenArticles or of associationMembers of the companyOfficers of the companyArticles of associationMemorandum of associationCompany adssUs securities exchangeMaples corporate servicesShareholder of the companyMember of the company

Deciphera Pharmaceuticals Announces Second Quarter 2023 Financial Results

– Second Quarter 2023 Total Revenue of $38.3 Million; Net Product Revenue for QINLOCK® (ripretinib) Increased 18% to $37.3 Million Compared to Second Quarter 2022 –– Top-line Results for MOTION Pivotal Phase 3 Study of Vimseltinib Expected in Fourth Quarter 2023 –– INSIGHT Pivotal Phase 3 Study of QINLOCK in Second-.

New zealandUnited statesUnited kingdomHong kongDaniell flynnDan flynnJamesa bristolMaghan meyersSteve hoerterDashyant dhanakDavid rosenPfizer incDeciphera pharmaceuticals incResearch engineExchange commissionDeciphera pharmaceuticals

Deciphera Pharmaceuticals Announces Retirement of Daniel L Flynn, Ph D , and Appointment of Dashyan

Deciphera Pharmaceuticals Announces Retirement of Daniel L Flynn, Ph D , and Appointment of Dashyan
pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.

United kingdomNew zealandUnited statesHong kongMaghan meyersJim bristolSteve hoerterJamesa bristolDashyant dhanakDaniell flynnDavid rosenChairperson or coCompany founderPfizer incDeciphera pharmaceuticalsUniversity of london